Varenicline-induced grand mal seizure

Australian adverse drug reactions bulletin. Volume 27, number 6. December 2008. Bennett DR, Ziter FA, Liske EA. Electroenphalographic effects of sleep deprivation in flying personnel. Neurology 1969; 19: 375–377. Coe JW, Brooks PR, Wirtz MC, Bashore CG, Bianco KE, Vetelino MG, et al. 3,5-Bicyclic aryl piperidines: A novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation. Bioorg Med Chem Lett 2005; 15: 4889–4897. Freedman R: Exacerbation of schizophrenia by varenicline. Am J Psychiatry 2007; 164: 1269. Garrison GD, Dugan SE. Varenicline: a first line treatment option for smoking cessation. Clin Ther 2009; 3: 463–491. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, et al. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 2007; 52: 985–994. Rxlist.com: http://www.rxlist.com/norvir-drug.htm.